What amount sold does Georgetown Opportunistic Fund Series LLC report in Form D filings?

The latest linked filings report $227.2M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Georgetown Opportunistic Fund Series LLC's most recent SEC filing?

Georgetown Opportunistic Fund Series LLC's most recent Form D filing was on 2022-08-16.

How many investors does Georgetown Opportunistic Fund Series LLC have?

The most recent Form D filing lists 9 investor(s).

What type of securities does Georgetown Opportunistic Fund Series LLC offer?

Georgetown Opportunistic Fund Series LLC's SEC Form D filings indicate equity offerings.

Georgetown Opportunistic Fund Series LLC

CIK: 0001682128·Pooled Investment Fund·WASHINGTON, DC·Limited Liability Company

Reported Sold

$227,200,000

Total Filings

Identified Offerings

Last Filed

Aug 16, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Aug 16, 2022Form D/A — Amendment

Reported sold: $227,200,000 · Target: Indefinite

Rule 506(b)·9 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Aug 13, 2021Form D/A — Amendment

Reported sold: $154,977,403 · Target: Indefinite

Rule 506(b)·9 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Aug 14, 2020Form D/A — Amendment

Reported sold: $103,700,000 · Target: Indefinite

Rule 506(b)·5 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Aug 16, 2019Form D/A — Amendment

Reported sold: $68,940,571 · Target: Indefinite

Rule 506(b)·4 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold

Aug 16, 2018Form D/A — Amendment

Reported sold: $38,485,433 · Target: Indefinite

Rule 506(b)·4 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Aug 21, 2017Form D/A — Amendment

Reported sold: $6,416,971 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(7)

Changed: Reported amount sold, Reported investors

Aug 22, 2016Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·0 investors·Section 3(c), Section 3(c)(7)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

86%

Latest reported sold across 1 identified offering

$227,200,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Afsaneh Mashayekhi Beschloss

Related Person

Appears on 7 filings

The Rock Creek Group, LP

Related Person

Appears on 7 filings

Rock Creek GP Holdings, LLC

Related Person

Appears on 7 filings

The Rock Creek Group, LLC

Related Person

Appears on 7 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 16, 2022	Amendment	Indefinite	$227,200,000	9
Aug 13, 2021	Amendment	Indefinite	$154,977,403	9
Aug 14, 2020	Amendment	Indefinite	$103,700,000	5
Aug 16, 2019	Amendment	Indefinite	$68,940,571	4
Aug 16, 2018	Amendment	Indefinite	$38,485,433	4
Aug 21, 2017	Amendment	Indefinite	$6,416,971	2
Aug 22, 2016	New	Indefinite	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Epsilon Healthcare Innovation Fund II, LP

Pooled Investment Fund

Offering target: $50,000,000

Filed Oct 30, 2026